Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants with Advanced Solid Tumors Recruiting

2025-523931-21-00 Advanced Malignant Solid Tumors 1 2026-04-07
Repurposing statins as adjuvants for cancer patients receiving therapy with immune checkpoint inhibitors: the STARK trial Recruiting

2024-518500-47-00 Non Small Cell Lung Cancer (NSCLC) 4 2026-04-07
Trial assessing fianlimab plus cemiplimab plus chemotherapy or cemiplimab plus chemotherapy in patients with pleural mesothelioma Recruiting

2024-519208-29-00 Pleural mesothelioma 4 2026-04-02
PHASE 1 STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF E-VIM VACCINE CVX1 WITH OR WITHOUT ICI IN THE TREATMENT OF SUBJECTS… Recruiting

2025-523781-25-00 metastatic solid cancer, muscle invasive bladder cancer 1 2026-04-02
Click-cleavable imaging in HER2-positive cancers (CleavHER trial). Recruiting

2025-520673-39-00 HER2-positive tumors 1 2026-04-02
Phase 1 open label trial of MST-0312 alone and in combination in subjects with solid malignancies Recruiting

2025-524446-10-00 Solid Malignancies 1 2026-04-01
A trial to learn how effective and safe datopotamab deruxtecan (Dato-DXd) is compared to docetaxel and how well Dato-DXd works in adults wit… Recruiting

2024-520101-39-00 TROP2 NMR-positive advanced or metastatic non-squamous 5 2026-04-01
The STELLAR trial: Fluorescence-guided surgery in laryngeal- and hypopharyngeal cancer: a feasibility trial Recruiting

2024-519750-36-00 Squamous cell carcinoma of the larynx and hypopharynx 7 2026-03-31
An Open-Label, Single-Arm Phase 1 Trial to Evaluate The Safety, Tolerability and Efficacy of Vididencel in Chronic Phase Chronic Myeloid Leu… Recruiting

2025-524587-37-00 Chronic Phase Chronic Myeloid Leukemia 3 2026-03-31
A clinical trial to learn about the effects of AMO959 given with AAA617 and an androgen receptor pathway inhibitor (ARPI) in adults with PSM… Recruiting

2025-521859-23-00 PSMA-positive mCRPC with prior exposure to at least one 9 2026-03-31
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination with Atezolizumab… Recruiting

2024-517490-24-00 Small Cell Lung Cancer 4 2026-03-31
Peri-operative intraperitoneal irinotecan and systemic FLOT in the curative treatment of gastric cancer and gastroesophageal junction cancer… Recruiting

2025-522864-34-00 Gastric cancer 3 2026-03-30
Pacritinib for Patients With Myelofibrosis Who Have Thrombocytopenia Recruiting

2025-522509-39-00 Patients with myelofibrosis and platelets counts betwee 4 2026-03-30
Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Previously Untreated, Unresectable, or Met… Recruiting

2025-523224-45-00 Untreated, Unresectable or Metastatic Colorectal Cancer 10 2026-03-30
A phase II, randomized, open-label, national, multicenter study evaluating the efficacy and safety of the combination of atezolizumab and be… Recruiting

2025-521459-22-00 Patients with resectable hepatocellular carcinoma (amen 4 2026-03-27
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors Recruiting

2025-524334-26-01 Advanced or metastatic solid tumors 1 2026-03-26
A Study of PHN-012 in Patients With Advanced Solid Tumors Recruiting

2025-523756-31-00 Advanced Solid Tumors 1 2026-03-26
A Phase 1/1b First-in-Human Study of BMS-986506 in ccRCC Recruiting

2025-522543-18-00 Advanced Clear Cell Renal Cell Carcinoma 1 2026-03-25
A clinical study of opevesostat and standard hormone therapy in people with prostate cancer (MK-5684-004) Recruiting

2023-504957-11-00 Metastatic castration resistant prostate cancer 5 2026-03-24
An early phase trial of RPTR-1-201 in Advanced Solid Tumors Recruiting

2025-524010-28-00 Advanced Solid Tumor 7 2026-03-20
(Title in lay language): A trial to learn how safe AZD0516 is and how well it works with and without other cancer treatments in adults with … Recruiting

2024-520026-11-00 Metastatic Prostate Cancer 7 2026-03-19
Phase III Study of Rilvegostomig in Combination withBevacizumab with or without Tremelimumab as First-lineTreatment of Hepatocellular Carcin… Recruiting

2024-518210-81-00 Advanced Hepatocellular Carcinoma 5 2026-03-18
Phase 2, Multicenter, Open label, Platform Study investigating ASP3082 in patients with Metastatic/Locally Advanced Non-Small-Cell Lung Canc… Recruiting

2025-522533-54-00 Metastatic Non-small cell lung cancer (NSCLC) and Pancr 4 2026-03-17
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3 Recruiting

2025-521621-33-00 Metastatic Melanoma 6 2026-03-16